BMS Global Site
Home   |   Site Index   |    Contact Us

What Sets Us Apart?
Enhancing Life
People Making a

Learning & Growing

Job Opportunities

Our Culture Home » What Sets Us Apart? » Enhancing Life

Enhancing Life

Globally, the Secure the Future program offers hope, care and support to women and children with HIV/AIDS in sub-Saharan Africa. Pursuing our mission also means Bristol-Myers Squibb acts as a responsible corporate citizen by expanding patient access to medicines around the globe and conducting business in a manner that contributes significantly to strong communities, a healthy environment and economic prosperity.

In India we have made significant R & D Expansion and Investment exemplified by our BMS Biocon Research Center (BBRC) – First investment to span discovery and development in India and an estimated investment USD 300 million over 8 years. When fully integrated, BBRC is estimated to house more than 400 scientists to help advance our discovery and early drug development efforts.

"Bristol-Myers Squibb, with an R&D spend of 17% globally, is amongst the world's top five drug companies with 65 product lines. In addition to its in-house research and development efforts, the company actively pursues products through research collaborations and strategic alliances. This enables is to leverage its partners' expertise and expand its capacity in a cost-disciplined way. Globally, the company has strategic research partnerships with other leading pharmaceutical companies such as Astrazeneca, Pfizer."
‘Taking wings – Coming of age of the Indian pharmaceutical outsourcing industry’ - Ernst & Young

  Employee Speaks

"At BMS we are committed to providing drugs that help patients live a longer and healthier life. This is reflected in our focus on discovering, developing and delivering drugs that help patients prevail over serious diseases."
Vijay Patel,
Business Unit Head

© 2009 Bristol-Myers Squibb
Your use of the information on this site is subject to the terms
of our Legal Notice and Privacy Policy.